Inflammation in Atherosclerosis: Thirty Years of Exploration in Basic and Clinical Science


This CME program covers the basic mechanisms of atherosclerosis, risk factors and diagnosis, the role of inflammation in acute coronary syndromes, and new therapie and management strategies.

Credits: 4.5

Fee: None

Expiration Date: April 20, 2010

Multimedia: Slide sets with text and audio

The Texas Heart Institute presents this online CME activity, which is “is intended for physicians with an interest in the prevention and treatment of atherosclerosis; physicians and scientists engaged in basic and clinical research of atherosclerosis; and professionals of the biotechnology and medical industry.”

Presented by Yong-Jian Geng, MD, and James T. Willerson, MD, of the Texas Heart Institute in Houston, TX, and Peter Libby, MD, and Paul M. Ridker, MD, from Brigham & Women’s Hospital in Boston, MA, this program “aims to link cutting-edge laboratory research with evolving clinical translation,” with emphasis on “the basic mechanism as well as clinical problems frequently encountered by today’s cardiologist.”

The course materials cover:

• The pathophysiology of atherosclerosis and the biomarkers of inflammation

• The role of inflammation in plaque fissuring/rupture and thrombosis in acute coronary syndromes

• The various therapeutic approaches in acute coronary syndromes

• The benefit of anti-inflammatory therapies in combination with newer antiplatelet and antithrombotic agents in acute coronary syndromes

• The evaluation and management of established and emerging coronary risk factors

• Appropriate selection of diagnostic tests in evaluation of cardiac patients

• The role of aggressive lipid-lowering therapy for primary and secondary prevention

• Controversies and new therapies for management of high-risk patients

• Evaluation and management of cardiac disorders in patients with highly inflammatory, rupture-prone plaques

• Review of various established practice guidelines for cardiovascular disorders

Click here to access this third-party online CME resource.

Related Videos
A panel of 5 cardiovascular experts
Video 5 - "Real-World Insights: Navigating Cardiac Myosin inhibitors in Practice" - Featuring 1 KOL
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Video 4 - "Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes "
Video 3 - "Aligning With 2023 ESC Guidelines in oHCM Treatment"
Robert Rosenson, MD | Credit: Cura Foundation
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Robert Rosenson, MD | Credit: Cura Foundation
© 2024 MJH Life Sciences

All rights reserved.